Patents by Inventor Ning Yin

Ning Yin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10331277
    Abstract: A touch projection screen includes a substrate, a first touch layer, a second touch layer, a reflective projection film and a circuit board. The substrate has a first surface and a second surface. The first touch layer is disposed on the first surface and extends around an edge of the substrate to cover a part of the second surface of the substrate. The second touch layer is disposed on the first touch layer and extends around an edge of the substrate to cover a part of the second surface of the substrate. The reflective projection film is disposed on the second touch layer. The circuit board is disposed on the second surface of the substrate and electrically connects the first and second touch layers. A touch projection system includes the touch projection screen and a projection device. The projection device projects an image beam onto the touch projection screen.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: June 25, 2019
    Assignee: Coretronic Corporation
    Inventors: Kun-Rong Chang, Nan-Jiun Yin, Pen-Ning Kuo
  • Publication number: 20190169393
    Abstract: Provided are insulative apparatus and methods of forming insulative apparatus. As an example, a method of forming an insulative apparatus can include connecting a barrier material to a mold; injecting a polyurethane foam composition into the mold, wherein the polyurethane foam composition includes a polyol, an isocyanate, and supercritical carbon dioxide; curing the polyurethane foam composition to form a polyurethane foam and applying a vacuum to the mold to provide a pressure from 1 millibar to 500 millibar.
    Type: Application
    Filed: July 29, 2016
    Publication date: June 6, 2019
    Applicant: Dow Global Technologies LLC
    Inventors: Ning Chai, Jing Chen, Yige Yin, Cheng Chen, Vanni Parenti
  • Publication number: 20180213223
    Abstract: Example implementations relate to translating a data structure to a video frame structure. For example, a computing device may perform a method of receiving analytic values of a data structure and converting the analytic values into raw pixel data such that each analytic value of the data structure is represented as a pixel in a video frame structure of pixels. The raw pixel data may be encoded into an I-frame in response to a determination that a difference between the raw pixel data and previous raw pixel data associated with previous analytic values exceeds a specified threshold. First data associated with at least one I-frame is retrieved in response to a request to view data changes exceeding the specified threshold.
    Type: Application
    Filed: July 31, 2015
    Publication date: July 26, 2018
    Applicant: ENT. SERVICES DEVELOPMENT CORPORATION LP
    Inventors: Jia-Yang LI, Tong-Ning YIN
  • Patent number: 9826419
    Abstract: Techniques for optimized cell acquisition for long term evolution (LTE) time division duplex (TDD) systems or closed subscriber group (CSG)/evolved Multicast Broadcast Multimedia Service (eMBMS) capable user equipments (UEs) are disclosed. A UE obtains configuration information, CSG capability information, and/or eMBMS capability information for a cell. The UE also stores the obtained information for the cell in a cell information database. In some aspects, the UE may employ the CSG and/or eMBMS capability information to select a weaker cell, during initial frequency scan at power up of the UE, based on cell capability. Additionally or alternatively, the UE may employ the configuration information to determine an initial mutual information (Mi) hypothesis value for physical hybrid-automatic repeat request (HART) indicator channel (PHICH) group mapping of the cell.
    Type: Grant
    Filed: April 13, 2015
    Date of Patent: November 21, 2017
    Assignee: QUALCOMM Incorporated
    Inventors: Pratik Kotkar, Alexei Yurievitch Gorokhov, Sachin Saraswat, Ning Yin, Srinivasan Rajagopalan, Muralidharan Murugan, Santosh Kumar Rongala
  • Publication number: 20170064764
    Abstract: Certain aspects relate to methods and apparatus for obtaining system information by an apparatus comprising concurrently maintaining a first buffer for combining multiple transmissions of at least a first type of system information block (SIB) message across different system information (SI) message windows and a second buffer for combining multiple transmissions of at least a second type of SIB message within an SI window, and decoding at least first and second types of SIB messages based on contents in the first and second buffers.
    Type: Application
    Filed: July 27, 2016
    Publication date: March 2, 2017
    Inventors: Lei KE, Raghu Narayan CHALLA, Udayan Murli BHAWNANI, Ning YIN, Daniel AMERGA
  • Publication number: 20150296391
    Abstract: Techniques for optimized cell acquisition for long term evolution (LTE) time division duplex (TDD) systems or closed subscriber group (CSG)/evolved Multicast Broadcast Multimedia Service (eMBMS) capable user equipments (UEs) are disclosed. A UE obtains configuration information, CSG capability information, and/or eMBMS capability information for a cell. The UE also stores the obtained information for the cell in a cell information database. In some aspects, the UE may employ the CSG and/or eMBMS capability information to select a weaker cell, during initial frequency scan at power up of the UE, based on cell capability. Additionally or alternatively, the UE may employ the configuration information to determine an initial mutual information (Mi) hypothesis value for physical hybrid-automatic repeat request (HART) indicator channel (PHICH) group mapping of the cell.
    Type: Application
    Filed: April 13, 2015
    Publication date: October 15, 2015
    Inventors: Pratik Kotkar, Alexei Yurievitch Gorokhov, Sachin Saraswat, Ning Yin, Srinivasan Rajagopalan, Muralidharan Murugan, Santosh Kumar Rongala
  • Patent number: 9108966
    Abstract: Aryl substituted diazabicyclooctanes (DBO) compounds that inhibit ?-lactamases of class A, class C or class D and potentiate ?-lactam antibiotics are disclosed. In particular, this disclosure provides DBO compounds that, when used in the disclosed Synergy MIC Assay with a ?-lactam antibiotic at a fixed concentration have an MIC of 8 ?g/mL or less against one or more isogenic ?-lactamase expressing bacterial strains.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: August 18, 2015
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Robert Busch, Roland E. Dolle, Chester A. Metcalf, III
  • Patent number: 8969570
    Abstract: Aryl substituted diazabicyclooctanes (DBO) compounds that inhibit ?-lactamases of class A, class C or class D and potentiate ?-lactam antibiotics are disclosed. In particular, this disclosure provides DBO compounds that, when used in the disclosed Synergy MIC Assay with a ?-lactam antibiotic at a fixed concentration have an MIC of 8 ?g/mL or less against one or more isogenic ?-lactamase expressing bacterial strains.
    Type: Grant
    Filed: March 29, 2013
    Date of Patent: March 3, 2015
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Robert Busch, Roland E. Dolle, Chester A. Metcalf, III
  • Patent number: 8962844
    Abstract: ?-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D ?-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Grant
    Filed: March 29, 2013
    Date of Patent: February 24, 2015
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Chester A. Metcalf, III, Dongpeng Wan
  • Patent number: 8962843
    Abstract: ?-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D ?-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Grant
    Filed: March 29, 2013
    Date of Patent: February 24, 2015
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Chester A. Metcalf, III
  • Publication number: 20150038482
    Abstract: ?-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D ?-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Application
    Filed: October 2, 2014
    Publication date: February 5, 2015
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Chester A. Metcalf, III, Robert Busch
  • Publication number: 20150038479
    Abstract: ?-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D ?-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Application
    Filed: October 2, 2014
    Publication date: February 5, 2015
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Chester A. Metcalf, III, Robert Busch
  • Publication number: 20150038478
    Abstract: Aryl substituted diazabicyclooctanes (DBO) compounds that inhibit ?-lactamases of class A, class C or class D and potentiate ?-lactam antibiotics are disclosed. In particular, this disclosure provides DBO compounds that, when used in the disclosed Synergy MIC Assay with a ?-lactam antibiotic at a fixed concentration have an MIC of 8 ?g/mL or less against one or more isogenic ?-lactamase expressing bacterial strains.
    Type: Application
    Filed: October 2, 2014
    Publication date: February 5, 2015
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Robert Busch
  • Publication number: 20150031665
    Abstract: ?-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D ?-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Application
    Filed: October 2, 2014
    Publication date: January 29, 2015
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Chester A. Metcalf, III, Robert Busch
  • Publication number: 20150031659
    Abstract: ?-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class ?-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Application
    Filed: October 2, 2014
    Publication date: January 29, 2015
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Chester A. Metcalf, III, Robert Busch
  • Publication number: 20150031666
    Abstract: ?-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D ?-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Application
    Filed: October 2, 2014
    Publication date: January 29, 2015
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Chester A. Metcalf, III, Robert Busch
  • Publication number: 20150031660
    Abstract: ?-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D ?-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Application
    Filed: October 2, 2014
    Publication date: January 29, 2015
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Chester A. Metcalf, III, Robert Busch
  • Patent number: 8940897
    Abstract: ?-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D ?-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Grant
    Filed: March 29, 2013
    Date of Patent: January 27, 2015
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Chester A. Metcalf, III
  • Publication number: 20150025053
    Abstract: The cephalosporin compound of formula (I) is disclosed, which exhibits antibiotic activity against Gram-negative (e.g., Pseudomonas aeruginosa) and Gram-positive (e.g., methicillin-resistant Staphylococcus aureus) bacteria. Methods of manufacturing the compound of formula (I), and uses of the compound in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Application
    Filed: July 17, 2014
    Publication date: January 22, 2015
    Applicant: CUBIST PHARMACEUTICALS, INC.
    Inventors: Yong He, Yu Gui Gu, Ning Yin
  • Patent number: 8933232
    Abstract: ?-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D ?-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Grant
    Filed: March 29, 2013
    Date of Patent: January 13, 2015
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Yu Gui Gu, Yong He, Ning Yin, Dylan C. Alexander, Jason B. Cross, Chester A. Metcalf, III